Factors associated with ethnical disparity in overall survival for patients with hepatocellular carcinoma

Oncotarget

Volumn 8, Issue 9, 2017, Pages 15193-15204

  Li, Juan ^a   Hansen, Bettina E ^a   Peppelenbosch, Maikel P ^a   De Man, Robert A ^a   Pan, Qiuwei ^a   Sprengers, Dave ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Ethnicity; Hepatocellular carcinoma; Overall survival; Race; Survival disparity

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HISPANIC; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; TUMOR VOLUME; CANCER REGISTRY; CANCER STAGING; ETHNICITY; ETHNOLOGY; HEALTH DISPARITY; LIVER TUMOR; MIDDLE AGED; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; ETHNICITY; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL RATE;

EID: 85014071313     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.14771     Document Type: Article

References (30)

1. Mittal S, El-Serag HB. Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol. 2013; 47:S2-6.
2. Wang S, Sun H, Xie Z, Li J, Hong G, Li D, Mallampati S, Zhou X, Zhou C, Zhang H, Cheng Z, Shan H, Ma H. Improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983-2012. Oncotarget. 2016; 7:59820-59833. doi: 10.18632/oncotarget.10930.
3. Artinyan A, Mailey B, Sanchez-Luege N, Khalili J, Sun CL, Bhatia S, Wagman LD, Nissen N, Colquhoun SD, Kim J. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States. Cancer. 2010; 116:1367-1377.
4. Xu L, Kim Y, Spolverato G, Gani F, Pawlik TM. Racial disparities in treatment and survival of patients with hepatocellular carcinoma in the United States. Hepatobiliary Surg Nutr. 2016; 5:43-52.
5. Davila JA, El-Serag HB. Racial differences in survival of hepatocellular carcinoma in the United States: a populationbased study. Clin Gastroenterol Hepatol. 2006; 4:104-110; quiz 104-105.
6. Sloane D, Chen H, Howell C. Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival. J Natl Med Assoc. 2006; 98:1934-1939.
7. Ha J, Yan M, Aguilar M, Tana M, Liu B, Frenette CT, Bhuket T, Wong RJ. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies. J Clin Gastroenterol. 2015.2016; 50:423-430.
8. Siegel AB, McBride RB, El-Serag HB, Hershman DL, Brown RS, Jr., Renz JF, Emond J, Neugut AI. Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002. Am J Gastroenterol. 2008; 103:120-127.
9. Mathur AK, Osborne NH, Lynch RJ, Ghaferi AA, Dimick JB, Sonnenday CJ. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. Arch Surg. 2010; 145:1158-1163.
10. Ananthakrishnan AN, Saeian K. Racial differences in liver transplantation outcomes in the MELD era. Am J Gastroenterol. 2008; 103:901-910.
11. Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, Thun M. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004; 54:78-93.
12. Hoehn RS, Hanseman DJ, Wima K, Ertel AE, Paquette IM, Abbott DE, Shah SA. Does race affect management and survival in hepatocellular carcinoma in the United States? Surgery. 2015; 158:1244-1251.
13. Altekruse SF, Henley SJ, Cucinelli JE, McGlynn KA. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol. 2014; 109:542-553.
14. Ha J, Yan M, Aguilar M, Bhuket T, Tana MM, Liu B, Gish RG, Wong RJ. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States. LID-10.1002/cncr.30103. (1097-0142 (Electronic)).
15. Alawadi ZM, Phatak UR, Kao LS, Ko TC, Wray CJ. Race not rural residency is predictive of surgical treatment for hepatocellular carcinoma: Analysis of the Texas Cancer Registry. Journal of Surgical Oncology. 2016:84-88.
16. Wong RJ, Devaki P, Nguyen L, Cheung R, Nguyen MH. Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: results from the Surveillance, Epidemiology, and End Results registry. Liver Transpl. 2014; 20:528-535.
17. Edge SB, American Joint Committee on C. AJCC cancer staging manual. (New York: Springer). 2010.
18. European Association For The Study Of The L, European Organisation For R, Treatment Of C. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012; 56:908-943.
19. Yau T, Tang VY, Yao TJ, Fan ST, Lo CM, Poon RT. Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma. Gastroenterology. 2014; 146:1691-1700 e1693.
20. Wang L, Wilson SE, Stewart DB, Hollenbeak CS. Marital status and colon cancer outcomes in US Surveillance, Epidemiology and End Results registries: does marriage affect cancer survival by gender and stage? Cancer Epidemiol. 2011; 35:417-422.
21. Martinez ME, Anderson K, Murphy JD, Hurley S, Canchola AJ, Keegan TH, Cheng I, Clarke CA, Glaser SL, Gomez SL. Differences in marital status and mortality by race/ethnicity and nativity among California cancer patients. Cancer. 2016; 122:1570-1578.
22. Gomez SL, Hurley S, Canchola AJ, Keegan TH, Cheng I, Murphy JD, Clarke CA, Glaser SL, Martinez ME. Effects of marital status and economic resources on survival after cancer: A population-based study. Cancer. 2016; 122:1618-1625.
23. Wang XD, Qian JJ, Bai DS, Li ZN, Jiang GQ, Yao J. Marital status independently predicts pancreatic cancer survival in patients treated with surgical resection: an analysis of the SEER database. Oncotarget. 2016; 7:24880-24887. doi: 10.18632/oncotarget.8467.
24. Hwang SJ, Tong MJ, Lai PP, Ko ES, Co RL, Chien D, Kuo G. Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America. J Gastroenterol Hepatol. 1996; 11:949-954.
25. Prenner S, Rinella ME. Moderate Exercise for Nonalcoholic Fatty Liver Disease. JAMA Intern Med. 2016; 176:1083-1084.
26. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996; 334:693-699.
27. Zak Y, Rhoads KF, Visser BC. Predictors of surgical intervention for hepatocellular carcinoma: race, socioeconomic status, and hospital type. Arch Surg. 2011; 146:778-784.
28. Freeman RB. Liver transplantation for hepatocellular carcinoma: racial disparities? Am J Gastroenterol. 2008; 103:128-130.
29. Sonnenday CJ, Dimick JB, Schulick RD, Choti MA. Racial and geographic disparities in the utilization of surgical therapy for hepatocellular carcinoma. J Gastrointest Surg. 2007; 11:1636-1646; discussion 1646.
30. Sarpel U, Suprun M, Sofianou A, Berger Y, Tedjasukmana A, Sekendiz Z, Bagiella E, Schwartz ME. Disentangling the effects of race and socioeconomic factors on liver transplantation rates for hepatocellular carcinoma. Clin Transplant. 2016: 30:714-721.